Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.

The aim of this study was to investigate the effect of size and charge on the permeation of nanoparticles through the skin as the first step in designing a transdermal vaccine delivery system. Fluorescent particles ranging in size and charge were applied to the surface of full thickness pig skin in a diffusion chamber and the receptor fluid was assayed to determine permeation. Fluorescence microscopy was used to visualise the skin after experiments. The results showed that only 50 and 500 nm particles that were negatively charged were able to permeate the skin. This provides evidence of the potential of nanoparticles as delivery vectors for antigens and DNA for the purpose of transdermal vaccination protocols. The results would indicate that negative particles with sufficient charge may be ideal carriers for this purpose.

[1]  C. Alving,et al.  Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. , 1998, Journal of immunology.

[2]  R H Guy,et al.  Characterization of the iontophoretic permselectivity properties of human and pig skin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[3]  C. Alving,et al.  Transcutaneous immunization: T cell responses and boosting of existing immunity. , 2001, Vaccine.

[4]  R. Mumper,et al.  Chitosan-based nanoparticles for topical genetic immunization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[5]  D. Tang,et al.  DNA-based non-invasive vaccination onto the skin. , 1999, Vaccine.

[6]  T. Tüting,et al.  DNA immunization targeting the skin: molecular control of adaptive immunity. , 1998, The Journal of investigative dermatology.

[7]  G. Glenn,et al.  Transcutaneous immunization of domestic animals: opportunities and challenges. , 2000, Advanced drug delivery reviews.

[8]  B. Kemppainen,et al.  Methods for Skin Absorption , 1990 .

[9]  S. Dittmann.  Vaccine safety: risk communication--a global perspective. , 2001, Vaccine.

[10]  P. Khavari,et al.  Immunization via hair follicles by topical application of naked DNA to normal skin , 1999, Nature Biotechnology.

[11]  S. Santoyo,et al.  PLGA microparticles: possible vehicles for topical drug delivery. , 2001, International journal of pharmaceutics.

[12]  G. Matyas,et al.  Skin immunization made possible by cholera toxin , 1998, Nature.

[13]  R. Mumper,et al.  Topical immunization using nanoengineered genetic vaccines. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[14]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[15]  G. Matyas,et al.  Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants , 1999, Infection and Immunity.